Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Rao

Showing results (221-230 of 292) with videos related to

Pageof 30
Sort By:
Cancer Immunology Research|February 19, 2022
CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous RetrovirusesYu Chen, Qiaomei Cai, Chaohu Pan, et al.
Cell Discovery|August 6, 2024
PROTAC for Bruton's tyrosine kinase degradation alleviates inflammation in autoimmune diseasesCan Zhu, Zimo Yang, Yuxiao Zhang, et al.
The Journal of Urology|April 21, 2010
Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcomeTobias Klatte, David B Seligson, Jian Yu Rao, et al.
The Journal of Physical Chemistry Letters|September 22, 2020
Dynamic Nuclear Polarization Enhancement of 200 at 21.15 T Enabled by 65 kHz Magic Angle SpinningPierrick Berruyer, Snædís Björgvinsdóttir, Andrea Bertarello, et al.
Journal of Medicinal Chemistry|April 24, 2020
Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A ReductaseMei-Xin Li, Yiqing Yang, Qiuye Zhao, et al.
Journal of Medicinal Chemistry|July 23, 2019
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera DegradersShang Su, Zimo Yang, Hongying Gao, et al.
Food Research International (Ottawa, Ont.)|May 17, 2024
Investigation into the potential mechanism of Bacillus amyloliquefaciens in the fermentation of broad bean paste by metabolomics and transcriptomicsHongbin Lin, Shiqi Liao, Zesu Zhou, et al.
American Journal of Clinical Pathology|October 30, 2009
Justification of the change from 10% to 30% for the immunohistochemical HER2 Scoring criterion in breast cancerYan-Hui Liu, Fang-Ping Xu, Jian-Yu Rao, et al.
British Journal of Pharmacology|May 19, 2026
Caspase Recruitment Domain 6 (CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technologyHonglian Li, Zhihao Ni, Yuzhen Rao, et al.
Frontiers in Genetics|January 24, 2022
A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung AdenocarcinomaWen-Yu Zhai, Fang-Fang Duan, Si Chen, et al.
Pageof 30

Showing results (221-230 of 292) with videos related to

Sort By:
Pageof 30
Cancer Immunology Research|February 19, 2022
CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous RetrovirusesYu Chen, Qiaomei Cai, Chaohu Pan, et al.
Cell Discovery|August 6, 2024
PROTAC for Bruton's tyrosine kinase degradation alleviates inflammation in autoimmune diseasesCan Zhu, Zimo Yang, Yuxiao Zhang, et al.
The Journal of Urology|April 21, 2010
Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcomeTobias Klatte, David B Seligson, Jian Yu Rao, et al.
The Journal of Physical Chemistry Letters|September 22, 2020
Dynamic Nuclear Polarization Enhancement of 200 at 21.15 T Enabled by 65 kHz Magic Angle SpinningPierrick Berruyer, Snædís Björgvinsdóttir, Andrea Bertarello, et al.
Journal of Medicinal Chemistry|April 24, 2020
Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A ReductaseMei-Xin Li, Yiqing Yang, Qiuye Zhao, et al.
Journal of Medicinal Chemistry|July 23, 2019
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera DegradersShang Su, Zimo Yang, Hongying Gao, et al.
Food Research International (Ottawa, Ont.)|May 17, 2024
Investigation into the potential mechanism of Bacillus amyloliquefaciens in the fermentation of broad bean paste by metabolomics and transcriptomicsHongbin Lin, Shiqi Liao, Zesu Zhou, et al.
American Journal of Clinical Pathology|October 30, 2009
Justification of the change from 10% to 30% for the immunohistochemical HER2 Scoring criterion in breast cancerYan-Hui Liu, Fang-Ping Xu, Jian-Yu Rao, et al.
British Journal of Pharmacology|May 19, 2026
Caspase Recruitment Domain 6 (CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technologyHonglian Li, Zhihao Ni, Yuzhen Rao, et al.
Frontiers in Genetics|January 24, 2022
A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung AdenocarcinomaWen-Yu Zhai, Fang-Fang Duan, Si Chen, et al.
Pageof 30